Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 2, 2000, Pages 619-622

  Pasquino, Anna Maria ^a   Pucarelli, Ida ^a   Roggini, Mario ^a   Segni, Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE; GROWTH HORMONE;

AGE; ARTICLE; BODY HEIGHT; BONE AGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; GONADORELIN TEST; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY; SHORT STATURE; SIDE EFFECT;

EID: 0034454578     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.2.6387     Document Type: Article

References (33)

1. Constitutional delay of growth and adolescence. Results of short-term and long-term treatment with GH
2. Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study and their response to growth hormone treatment
3. Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature
4. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues
5. Final height of short normal children treated with growth hormone
6. Final height of short normal children treated with growth hormone
7. Final height in non-growth hormone deficient children treated with growth hormone
8. Short- and long-term (final height) data in children with normal variant short stature treated with growth hormone
9. Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure
10. Randomised trial of growth hormone in short normal girls
11. Effect of growth hormone treatment on adult height of children with idiopathic short stature
12. Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue
13. Effect of deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: Preliminary results
14. Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development
15. Luteinizing hormone-releasing hormone agonist (LHRHa)-induced delay of epiphyseal fusion increases adult height of adolescents with short stature
16. Tables for predicting adult height from skeletal age: Revised for use with the Greulich and Pyle hand standards
17. Variations in pattern of pubertal changes in girls
18. Standards for children's height at ages 2-9 allowing for height of parents
19. Ovaries in sexual precocity
20. Long-term results with a slow-release gonadotrophin-release hormone agonist in central precocious puberty
21. The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty
22. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis
23. Use of combined Gn-RH agonist and hGH therapy for better attaining the goals in precocious puberty treatment
24. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty
25. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone
26. Adult height in 24 patients treated for growth hormone deficiency and early puberty
27. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue
28. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist
29. Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls
30. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone
31. Final height in short-normal girls treated with growth hormone plus GnRH-analogs. Further data on new cases and comparison with an untreated control group
32. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty